Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma

Virchows Archiv

Volumn 462, Issue 1, 2013, Pages 83-93

  Mogi, Ai ^a   Koga, Kaori ^a   Aoki, Mikiko ^a   Hamasaki, Makoto ^a   Uesugi, Noriko ^b   Iwasaki, Akinori ^a   Shirakusa, Takayuki ^c   Tamura, Kazuo ^a   Nabeshima, Kazuki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Fukuseikai Hospital   (Japan)

Author keywords

GLUT 1; Malignant mesothelioma; MCT 1; MCT 4

Indexed keywords

GLUCOSE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; RNA; SMALL INTERFERING RNA;

ADULT; APOPTOSIS; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REACTIVE MESOTHELIAL HYPERPLASIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE PROTEINS; ONCOGENE PROTEINS; PLEURAL NEOPLASMS; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84872353780     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1344-6     Document Type: Article

References (31)

1. Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636-2644
2. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
3. Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT (1997) Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80:1046-1051
4. Idrees MT, Schlosshauer P, Li G, Burstein DE (2006) GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma. Histopathology 49:75-81
5. Brown RS, Wahl RL (1993) Overexpression of Glut-1 glucose transporter in human breast cancer. An Immunohistochemical Study. Cancer 72:2979-2985
6. Wang BY, Kalir T, Sabo E, Sherman DE, Cohen C, Burstein DE (2000) Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88:2774-2781
7. Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343(Pt 2):281-299
8. Fang J, Quinones QJ, Holman TL et al (2006) The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 70:2108-2115
9. Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, Seacotte N, Drewes LR (2001) Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 12:761-765
10. Pinheiro C, Albergaria A, Paredes J et al (2010) Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56:860-867
11. Pinheiro C, Longatto-Filho A, Scapulatempo C et al (2008) Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 452:139-146
12. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66:632-637
13. Rofstad EK, Mathiesen B, Kindem K, Galappathi K (2006) Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66:6699-6707
14. Kato Y, Tsuta K, Seki K et al (2007) Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol 20:215-220
15. Shen J, Pinkus GS, Deshpande V, Cibas ES (2009) Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol 131:516-523
16. Monaco SE, Shuai Y, Bansal M, Krasinskas AM, Dacic S (2011) The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol 135:619-627
17. Travis WD, World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon
18. Al-Haddad S, Zhang Z, Leygue E et al (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155:2057-2066
19. Usami N, Fukui T, Kondo M et al (2006) Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci 97:387-394
20. Aoki M, Nabeshima K, Koga K, Hamasaki M, Suzumiya J, Tamura K, Iwasaki H (2007) Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB. Lab Investig 87:767-779
21. Pinheiro C, Longatto-Filho A, Soares TR et al (2012) CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma. Diagn Cytopathol 40:478-483
22. Baba M, Inoue M, Itoh K, Nishizawa Y (2008) Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem Biophys Res Commun 374:111-116
23. Mathupala SP, Parajuli P, Sloan AE (2004) Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 55:1410-1419, discussion 1419
24. Sonveaux P, Vegran F, Schroeder T et al (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930-3942
25. Izumi H, Takahashi M, Uramoto H et al (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102:1007-1013
26. Harvey P, Clark IM, Jaurand MC, Warn RM, Edwards DR (2000) Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br J Cancer 83:1147-1153
27. Hasteh F, Lin GY, Weidner N, Michael CW (2010) The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 118:90-96
28. Ozbudak IH, Shilo K, Tavora F et al (2009) Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis. Mod Pathol 22:633-638
29. Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202:654-662
30. Fan J, Zhou JQ, Yu GR, Lu DD (2010) Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro. Cancer Biother Radiopharm 25:521-527
31. Amann T, Maegdefrau U, Hartmann A et al (2009) GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 174:1544-1552